Kenvue Shares Slip 0.3% as Shareholders Approve 99% Acquisition Vote
Shares of Kenvue fell 0.3% to $18.48 in Thursday premarket trading despite no new catalyst. Shareholders voted 99% in favor of Kimberly-Clark’s takeover, slated to close in the second half of 2026.
1. Premarket Trading and Technical Indicators
Kenvue shares slipped 0.3% to $18.48 in premarket trading despite no new announcements. The stock trades 4.6% above its 20-day SMA and 10.7% above its 100-day SMA, with an RSI of 73.07 indicating overbought conditions and potential pullback risk.
2. Shareholder Approval Achieved
At its special meeting, 99% of votes cast supported the proposals required for Kimberly-Clark’s acquisition of Kenvue, marking a key milestone in the merger process. This overwhelming endorsement clears a major hurdle toward consolidation of their health and wellness portfolios.
3. Acquisition Timeline and Next Steps
The transaction remains subject to final regulatory approvals and is expected to close in the second half of 2026. Management anticipates enhanced innovation and market expansion once the combined entity is fully integrated.